Orion Portfolio Solutions’s Catalyst Pharmaceutical CPRX Stock Holding History

Orion Portfolio Solutions’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$262K	Buy	+10,820	New	+$244K	﹤0.01%	1685
2024 Q4	–	Sell	-13,212	Closed	-$263K	–	1838
2024 Q3	$263K	Sell	13,212 -80	-0.6%	-$1.48K	﹤0.01%	1588
2024 Q2	$206K	Sell	13,292 -190	-1%	-$2.96K	﹤0.01%	1630
2024 Q1	$215K	Buy	13,482 +3,199	+31%	+$48.2K	﹤0.01%	1587
2023 Q4	$155K	Sell	10,283 -2,645	-20%	-$36.2K	﹤0.01%	1603
2023 Q3	$151K	Sell	12,928 -886	-6%	-$11.9K	﹤0.01%	1571
2023 Q2	$186K	Buy	13,814 +3,155	+30%	+$45.4K	﹤0.01%	1563
2023 Q1	$177K	Buy	+10,659	New	+$176K	﹤0.01%	1506

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Orion Portfolio Solutions's CPRX Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2025: 10,820 shares worth $262K. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in CPRX as recently as Q3 2024.

Orion Portfolio Solutions first reported a position in CPRX in Q1 2023 and has held it in 8 quarters since. The position peaked at $263K in Q3 2024. 371 funds tracked by Wall St. Rank hold CPRX as of Q1 2025.

Orion Portfolio Solutions held 10,820 shares of Catalyst Pharmaceutical worth $262K as of Q1 2025.
Catalyst Pharmaceutical was a new Orion Portfolio Solutions position in Q1 2025.
Catalyst Pharmaceutical made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1685 holding.
Orion Portfolio Solutions first reported a position in Catalyst Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
Orion Portfolio Solutions's Catalyst Pharmaceutical position peaked at $263K in Q3 2024.
371 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.